GLP-1 RA-based therapy can be initiated or continued in dialysis patients for cardiovascular risk reduction
Many products marketed as "GLP-1 supplements" claim to naturally increase GLP-1 activity or act as alternatives to prescription medications
Its a product launch the manufacturer never scheduled
Examples include pancreatic beta-cell lines (e.g., INS-1, MIN6) for studying insulin secretion, adipocyte cell lines (e.g., differentiated 3T3-L1 cells) for investigating lipid metabolism and adipokine secretion, or hypothalamic neuronal cell lines for exploring central signaling pathways
Side effects can have varying impacts on individuals as everyone is different
For individuals using GLP-1 medications to manage weight loss, strength training helps maintain functional strength, preventing the loss of muscle that often accompanies aging or extended periods of inactivity